Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 December 2019 | Story Valentino Ndaba | Photo Valentino Ndaba
Lesotho Read More
Staff members from the National University of Lesotho and the University of the Free State at the signing of the Memorandum of Understanding.

Cornelius Hagenmeier, Director of the Office for International Affairs, quoted from the 2018–2020 Internationalisation Strategy, which states, “Out of the existing partnerships and collaborations, a limited number of strategic partnerships will be identified and specifically supported. Furthermore, the development of a strategic partnership with the National University of Lesotho will be explored.”  

This agenda became official on 17 October 2019 when the National University of Lesotho and the University of the Free State signed a Memorandum of Understanding.  
 
Building bridges to reach critical regional partners
 

This ongoing organic collaboration has been evident in different spheres of our university over the past few years. Joint activities are already taking place through the Directorate for Research Development that is driving the Lesotho Highlands Water Project, the Faculty of Education, Pharmacology, Political Studies, Africa Studies, and the Afromontane Research Unit on the UFS Qwaqwa Campus. 

Delegates who represented the National University of Lesotho at the signing ceremony were the Dean of the Faculty of Health Sciences, Prof Sunny Aiyuk; Dean of the Faculty of Social Sciences, Prof Motlamelle Kapa; Dean of the Faculty of the Humanities, Prof Beatrice Ekanjume-Ilongo; and Senior Lecturer in Development Studies and Chair of the Gender Committee, Dr Mamoeketsi Ntho.  

Internationalisation, Africanisation, and decolonisation
  

The conclusion of a formal Memorandum of Understanding, which contributes towards academic growth, reflects the vision of comprehensive internationalisation at both institutions.   
 
According to the UFS Internationalisation Strategy, “Internationalisation, Africanisation and decolonisation are considered as contemporary processes. In line with the South African policy priorities, the internationalisation process at the UFS will in the future include a stronger focus on the Southern African Development Community (SADC), Africa, BRICS, and the Global South. Nevertheless, the university will continue to strengthen and expand its relations and partnerships in the Global North.”  

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept